Worldwide experiences and opinions of healthcare providers on eHealth for patients with interstitial lung diseases in the COVID-19 era
Gizal Nakshbandi, Catharina C. Moor, Kerri A. Johannson, Toby M. Maher, Michael Kreuter, Marlies Wijsenbeek
Abstract
<b>The #COVID19 pandemic has led to an increase in the use of eHealth for patients with interstitial lung disease. Healthcare providers worldwide are positive towards further implementation of eHealth for research and clinical practice.</b>https://bit.ly/3h2545M
Topics & Concepts
eHealthMedicineCoronavirus disease 2019 (COVID-19)Health carePandemicInterstitial lung diseaseTelemedicineHealth professionalsSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Family medicine2019-20 coronavirus outbreakDiseaseLungInternal medicineVirologyInfectious disease (medical specialty)EconomicsOutbreakEconomic growthInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisChronic Obstructive Pulmonary Disease (COPD) ResearchInhalation and Respiratory Drug Delivery